Source / episode info

• **Episode:**301
• **Title:**Divine Intervention Episode 301 – Diabetes and The USMLEs Part 1.
• **Published:**2021-04-04
• Source:Episode page

One-liner

Episode 301 provides a comprehensive review of diabetes mellitus pathophysiology, covering the autoimmune mechanisms of Type 1 DM (CTLA-4 mutation), the insulin resistance and counter-regulatory hormone dominance in Type 2 DM, and detailed pharmacology of key agents like Metformin, SGLT2 inhibitors, and GLP-1 receptor agonists.

High-yield summary

• Pathophysiology: The final common pathway for all diabetic complications is chronic hyperglycemia, leading to microvascular damage (retinopathy, nephropathy) and macrovascular disease (MI).
• Type 1 DM Diagnosis: Look for acute onset symptoms (polyuria/polydipsia), weight loss, and consider the diagnosis if C-peptide levels are low or undetectable. A failure of C-peptide rise after a glucagon infusion is highly diagnostic.
• Insulin Mechanism: Insulin release is triggered by glucose entering pancreatic beta cells via GLUT2 receptors, leading to ATP production that closes K+ channels, depolarizes the cell, and opens voltage-gated Ca++ channels.
• Metformin Action: Increases insulin sensitivity by activating AMPK, which inhibits key enzymes in hepatic gluconeogenesis: PEPCK (Phosphoenolpyruvate carboxykinase) and Glucose-6-phosphatase.
• SGLT2 Inhibitors: Block the SGLT2 transporter in the proximal convoluted tubule, causing glucosuria, weight loss, and reducing cardiovascular risk; caution is needed in renal impairment.

Learning objectives

• Describe the pathophysiology, clinical presentation, and diagnostic workup distinguishing Type 1 from Type 2 diabetes mellitus.
• Explain the molecular mechanism of insulin secretion in pancreatic beta cells following glucose ingestion.
• Analyze the mechanisms of action, side effects, and contraindications for major classes of anti-diabetic agents (e.g., Metformin, SGLT2 inhibitors).
• Interpret laboratory findings related to diabetic emergencies (DKA vs. HHS) and C-peptide levels in different types of diabetes.
• Understand how counter-regulatory hormones contribute to hyperglycemia during stress or illness.

Board exam buzzwords